LAVA Therapeutics Ownership | Who Owns LAVA Therapeutics?


OverviewForecastRevenueFinancialsChart

LAVA Therapeutics Ownership Summary


LAVA Therapeutics is owned by 14.03% institutional investors, 28.72% insiders, and 57.25% retail investors. Redmile group is the largest institutional shareholder, holding 7.74% of LVTX shares. Bruce is the top mutual fund, with 2.94% of its assets in LAVA Therapeutics shares.

LVTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLAVA Therapeutics14.03%28.72%57.25%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Redmile group2.07M7.74%$3.73M
Bruce771.87K2.88%$1.39M
Sphera funds management367.58K1.37%$661.65K
Two sigma investments, lp112.44K0.42%$202.39K
Alpha wave global, lp87.40K0.33%$157.31K
Susquehanna group, llp73.10K0.27%$131.58K
Pnc financial services group65.00K0.24%$117.00K
Pathway financial advisors60.00K0.22%$108.00K
Two sigma advisers, lp31.70K0.12%$57.06K
Millennium management26.49K0.10%$47.69K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bruce771.87K0.46%$1.39M
Redmile group2.07M0.23%$3.73M
Sphera funds management367.58K0.09%$661.65K
Alpha wave global, lp87.40K0.05%$157.31K
Pathway financial advisors60.00K0.03%$108.00K
Tang capital management5.11K0.00%$9.20K
Two sigma investments, lp112.44K0.00%$202.39K
Tsfg400.000.00%$1.00K
Two sigma advisers, lp31.70K0.00%$57.06K
Pnc financial services group65.00K0.00%$117.00K

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp73.10K-55.40K
Pathway financial advisors60.00K0.03%46.00K
Two sigma investments, lp112.44K0.00%30.41K
Two sigma advisers, lp31.70K0.00%15.00K
Millennium management26.49K-6.46K

Top Sellers

HolderShares% AssetsChange
Walleye capital25.68K0.00%-128.99K
Xtx topco---30.81K
Alpha wave global, lp87.40K0.05%-20.51K
Schonfeld strategic advisors---18.30K
Bank of america corp /de/400.00--15.01K

Sold Out

HolderChange
Simplex trading-2.59K
Ubs group-8.98K
Two sigma securities-12.91K
Schonfeld strategic advisors-18.30K
Xtx topco-30.81K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202421-8.70%3,758,209-0.08%147.11%9-30.77%3-
Mar 31, 20242364.29%3,761,071-35.55%142.85%13225.00%3-25.00%
Dec 31, 202314-5,835,4382.05%224.69%4300.00%4100.00%
Sep 30, 202314-12.50%5,718,284-0.49%214.55%1-88.89%2-
Jun 30, 202316-15.79%5,746,405-14.73%213.33%928.57%2-66.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Bruce771.87K2.94%-
Mutual Fund Evli Hannibal156.83K0.60%-
Mandarine Global Microcap G EUR27.50K0.10%7.50K
Fidelity Nasdaq Composite Index11.12K0.04%-

LVTX Ownership FAQ


Who Owns LAVA Therapeutics?

LAVA Therapeutics shareholders are primarily institutional investors at 14.03%, followed by 28.72% insiders and 57.25% retail investors. The average institutional ownership in LAVA Therapeutics's industry, Biotech Stocks , is 44.97%, which LAVA Therapeutics falls below.

Who owns the most shares of LAVA Therapeutics?

LAVA Therapeutics’s largest shareholders are Redmile group (2.07M shares, 7.74%), Bruce (771.87K shares, 2.88%), and Sphera funds management (367.58K shares, 1.37%). Together, they hold 11.99% of LAVA Therapeutics’s total shares outstanding.

Does Blackrock own LAVA Therapeutics?

BlackRock is not among the top 10 institutional shareholders of LAVA Therapeutics.

Who is LAVA Therapeutics’s biggest shareholder by percentage of total assets invested?

Bruce is LAVA Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.46% of its assets in 771.87K LAVA Therapeutics shares, valued at 1.39M$.

Who is the top mutual fund holder of LAVA Therapeutics shares?

Bruce is the top mutual fund holder of LAVA Therapeutics shares, with 2.94% of its total shares outstanding invested in 771.87K LAVA Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools